Home › Products › Oncology › Palbodel 125mg Tablet
Palbodel 125mg Tablet
Salt Composition: PALBOCICLIB
- Manufacturer: DELARC PHARMACEUTICALS
- Pack Size: 21 TABLET(s) IN A BOTTLE
- Dosage Form: TABLET
- Strength: 120MG
- Prescription Required
- Storage: Keep Palbopro 125 mg Capsule out of sight and reach of children. Store at 20°C to 25°C.
₹2250.00₹5609.06
Inclusive of all taxes
Product Introduction
Palbociclib 125 mg tablet is a targeted anticancer therapy belonging to the class of cyclin-dependent kinase inhibitors. It is indicated for the treatment of hormone receptor-positive, human epidermal growth factor 2 negative advanced or metastatic breast cancer in combination with other anticancer medications. Cancer occurs when cells multiply in an uncontrolled and abnormal manner.
Common side effects associated with palbociclib 125 mg tablet include nausea, vomiting, diarrhoea, tiredness, hair loss, dry skin, rash, infections, nosebleed, decreased appetite, low blood cell counts, swelling of lips and mouth, changes in taste, dry eye, blurred vision, and increased tearing. Inform your doctor if any of these side effects occur or persist.
Inform your healthcare provider if you are allergic to palbociclib 125 mg tablet or any of its ingredients. Before commencing treatment, it is essential to inform your doctor if you have signs of infection (fever, chills, or sore throat), liver disorders, kidney disorders, or intolerance to certain sugars. Consult your physician immediately if you experience dry cough, chest pain, or difficulty breathing, as these may indicate lung inflammation. Inform your physician of all medicines, including supplements and herbal medicines, that you are taking before starting treatment with this medication.
Effective birth control should be used during treatment and for at least three weeks after the final dose. This medication is not recommended for adolescents and children under 18 years of age.
Uses
Treatment of hormone receptor (HR)-positive, human epidermal growth factor 2 (HER2)-negative advanced or metastatic breast cancer.
How it works
Palbopro 125 mg Capsule works by blocking the protein called cyclin-dependent kinases 4 and 6, which are vital for the division and growth of cells. By blocking these proteins, this medication slows the growth and prevents the cancer cells from spreading.
How to Use
Take the Palbopro 125 mg Capsule exactly as prescribed by your doctor. Take this medication once a day at the same time with food. Swallow this capsule as a whole with a glass of water. Avoid crushing, breaking, or chewing the capsule.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. Serious: Blood disorder (fever, chills, shortness of breath, weakness, bleeding, or bruising) Lung inflammation (chest pain, dry cough, or difficulty breathing) Common: Tiredness Hair loss Dry skin, rash Infections Low blood cell counts. Decreased of appetite Nausea, vomiting
Expert Tips
During Palbopro 125 mg Capsule treatment, it is advised to avoid grapefruit and its juices and preparations containing St. John's wort. It is recommended to use effective birth control while receiving treatment as well as for at least three weeks after the final dose for females and at least fourteen weeks after the final dose for males. This medication may reduce fertility, so discuss with the physician if you have any concerns. Your doctor may recommend regular blood tests to determine whether Palbopro 125 mg Capsule affects your blood cells.
References
- Pfizer Limited, Electronic medicines compendium (emc), [Revised on June 2021] [ Accessed on 26 Nov 2022], https://www.medicines.org.uk/emc/files/pil.4449.pdf
- Pfizer Labs, US Food and Drug Administration, [Revised on March 2017] [ Accessed on 26 Nov 2022], https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207103s004lbl.pdf
- Neha S Mangini et al; Palbociclib: A Novel Cyclin-Dependent Kinase Inhibitor for Hormone Receptor-Positive Advanced Breast Cancer; The Annals of Pharmacotherapy; Published on Nov 2015; Accessed on 26/11/2022; https://pubmed.ncbi.nlm.nih.gov/26324355/
- Palbace; Pfizer; Revised on Oct 2021; Accessed on 26/11/2022; https://labeling.pfizer.com/ShowLabeling.aspx?id=14029
Safety Advice
Pregnancy: unsafe It is not recommended to take Palbopro 125 mg Capsule during pregnancy as it can harm the unborn baby. Women with childbearing potential should use effective contraceptives during treatment and for at least three weeks after treatment.
Lungs: Consult your doctor You need to tell your physician if you have any lung disorders before taking Palbopro 125 mg Capsule, as this medication should be used with caution in kidney disorder
Breastfeeding: unsafe It is not recommended to take Palbopro 125 mg Capsule while breastfeeding as it is not known whether it passes into the breast milk. consult your healthcare provider before taking this capsule.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.